hypomethylating - Globe Thesis

Keyword [hypomethylating] Result: 1 - 20 \| Page: 1 of 1
1.	Abnormal Celluar Immunity And Treatment Of Myelodysplastic Syndrome
2.	A Retrospective Study Of Decitabine-based Regimes For Patients With Myelodysplastic Syndromes-RAEB
3.	The Mechanism And Anti-myeloma Immunity Effects Of Combined Treatment With Hypomethylating Drug And Donor Lymphocyte Infusion In Multiple Myeloma
4.	Clinical Outcome Of Treatment With A Combined Regimen Of Decitabine Followed By Low-dose Idarubicin And Cytarabine For Patients With High-risk Myelodysplastic Syndromes And AML Transformed From Myelodysplastic Syndromes(MDS/AML)
5.	The Research On The Relationship Between The Methylation Of THBS1 Genes And Pathogenesis Of Acute Myeloid Leukemiaand The Role Of Hypomethylating Agents In Hematopoietic Stem Cell Transplantation
6.	Efficacy And Safety Of Hypomethylating Agents And Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Myelodysplastic Syndrome:a Meta-analysis
7.	WT1 MRNA Expression Level In Patients With Myelodysplastic Syndromes At Stable Disease After Hypomethylating Agents
8.	Multivariate Analysis Of Overall Survival In Elderly Patients With Acute Myeloid Leukemia
9.	Impression Of Different Scoring Systems And Gene Mutations For The Prognosis Of Myelodysplastic Syndrome(MDS)
10.	Analysis Of The Clinical Effect Of Decitabine Alone Or In Combination With CAG Regimen In The Treatment Of Newly Diagnosed Acute Myeloid Leukemia
11.	Effects Of Hypomethylating Agents On Tregs,Th1,Th2 And NKT In Patients With AML/MDS
12.	The Effect Of Combining Hypomethylating Agents With Histone Deacetylase Inhibitors To Affect THP-1cells
13.	Maximizing efficacy of the hypomethylating drug 5-aza-2'-deoxycytidine in human leukemia
14.	Expression Of WT-1 And LDH In Patients With Myelodysplastic Syndrome And Dynamic Changes After HMA Treatment
15.	Meta-analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors Combined With Hypomethylating Agents In The Treatment Of Acute Myeloid Leukemia And Myelodysplastic Syndromes
16.	Analysis Of The Therapeutic Effect Of Decitabine Combined With CAG Regimen In The Treatment On 66 Elderly Patients With Acute Myeloid Leukemia
17.	Efficacy And Safety Of BCL-2 Inhibitor (Venetoclax) In Treatment Of Elderly Patients With Acute Leukemia:A Systematic Review And Meta-analysis
18.	The Treatment Of The Myelodysplastic Syndrome With TADA Or Decitabine Retrospective Analysis
19.	Analysis Of The Efficacy And Safety Of Hypomethylating Agents In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndromes
20.	Study On The Correlation Between U2AF1 Gene Mutation Characteristics And Prognosis In Patients With Myelodysplastic Syndrome
<<First <Prev Next> Last>> Jump to